Skip to content

PET study of central PDE10A density and tau deposition in bipolar disorder.

PET study of central PDE10A density and tau deposition in bipolar disorder. - PET study of central PDE10A density and tau deposition in bipolar disorder.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029608
Enrollment
50
Registered
2017-11-01
Start date
2017-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer, bipolar disorder.

Interventions

Sponsors

National Institute of Radiological Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: I. Patients 20 y.o.<=Age patients with bipolar disorder or shizoaffective disorder II. Healthy volunteers 20 y.o.<=Age normal subjects

Exclusion criteria

Exclusion criteria: I. Patients 1. Subjects with other psychiatric diseases 2. Subjects with any organic brain disorder 3. Subjects with a severe physical complication 4. Subjects who has been taking papaverine or xanthine 5. Subjects with metallic medical device in the body 6. Subjects with tattoo 7. Subjects with severe claustrophobia 8. Subjects who tends to suicide 9. Pregnant women 10. Subjects who is considered to be inappropriate to participate in the study II. Healthy volunteers 1. Subjects with any psychiatric disorder 2. Subjects with any organic brain disorder 3. Subjects with severe physical complication 4. Subjects who has been taking papaverine or xanthine 5. Subjects who has been taking any dopamine blocker 6. Subjects who currently smokes 7. Subjects with metallic medical device in the body 8. Subjects with tattoo 9. Subjects with severe claustrophobia 10. Pregnant women 11. Subjects who has participated in other study in recent 6 months. 12. Subjects who is considered to be inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Binding potential measured by positron emission tomography with [18F]MNI659 and [18F]PM-PBB3

Secondary

MeasureTime frame
Correlations between central PDE10A and tau deposition and various clinical scales Difference of binding potential of [18F]MNI659 between manic state and depressive state.

Countries

Japan

Contacts

Public ContactKeisuke Takahata

National Institute of Radiological Sciences Department of Functional Brain Imaging Research

takahata.keisuke@qst.go.jp81432063025

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026